$AVAH

J.H. Whitney Equity Partners VII, LLC sold $7.4M of AVAH (indirect holdings)

J.H. Whitney Equity Partners VII, LLC sold 919,389 indirectly-held shares of Aveanna Healthcare Holdings, Inc. (AVAH) at $8.00 ($7.36M total) on 2026-06-24.

Original reporting
SEC EDGAR · J.H. Whitney Equity Partners VII, LLC
Published Jun 26, 2026, 5:35 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 26, 2026, 5:50 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$AVAH
Neutral
medium confidence
Mentioned
$AVAH
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AVAHNeutralLow
01

Why it matters

The newest fact is the disclosed open-market sale: 919,389 shares for ~$7.36M at $8.00/share on 2026-06-24, reported by a 10% owner via indirect holdings.

02

Market read

Traders may briefly reassess sentiment around AVAH due to the disclosed owner selling, but there is no new guidance, earnings, or regulatory development.

03

What to watch

The filing notes no pre-arranged 10b5-1 plan, which may lead traders to over-interpret intent; also, the post-sale share count remains substantial, so the sale may not imply a full exit.

Relevance 6/10Novelty 5/10Timing: filed 2026-06-26 after-hours/late session; transaction dated 2026-06-24

Background

The article is a primary-source SEC Form 4 insider transaction disclosure for Aveanna Healthcare Holdings, Inc. (AVAH).

Company-level read

Ticker impact

$AVAHNeutralMedium confidence
Context

Aveanna Healthcare Holdings disclosed a 10% owner indirect open-market sale of 919,389 shares at $8.00 on 2026-06-24 via Form 4.

Expected impact

Likely limited near-term impact; any effect is sentiment-driven and typically fades unless accompanied by other disclosures.

Evidence & confidence

Form 4 provides a concrete transaction (size, price, date) but no new operating, regulatory, or guidance information. The filing also states no pre-arranged 10b5-1 plan, which can increase scrutiny, yet it remains a single sale disclosure.

Market effects

Minimal; this is company-specific insider selling with no sector-wide signal.

None indicated.

None indicated.

Counterpoint

A large indirect sale by a 10% owner can be routine liquidity/portfolio rebalancing rather than a bearish signal, especially without any accompanying negative company news.

Key entities

  • Aveanna Healthcare Holdings, Inc.

    Subject of the Form 4 insider transaction; ticker AVAH.

  • J.H. Whitney Equity Partners VII, LLC

    Reporter of the indirect open-market sale transaction.

Related articles

$AVAHMed

Bain, KKR, KV Asia shortlisted for Malaysia’s Avisena Healthcare stake sale as valuation hits US$368 million: sources

Bain Capital, KKR and KV Asia have been shortlisted to buy a 20–25% minority stake in Malaysia’s Avisena Healthcare, valuing the company at about RM1.5 billion (US$368m), according to two sources. Binding bids are due by end-July. The stake is estimated at RM300–400m. KKR and Bain declined comment; Avisena and KV Asia did not respond.